Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic. According to the company, Incruse contains 62.5mcg umeclidinium and is delivered
The collaboration aligns the research efforts of both firms around projects which are designed to develop a deep understanding of the pathogenesis and progression of MS and to
The trial is designed to further evaluate the safety, tolerability and efficacy of certain doses of FX006. FX006 is designed to offer prolonged pain relief for the treatment
The merger, in combination with an expansive capital investment program, will create product development and production capabilities across 600,000ft² of manufacturing space. The combined scale and breadth of
As part of the deal, REGENX granted AAVLife an exclusive worldwide license, with rights to sublicense, to deliver its NAV rAAVrh10 vector via non CNS routes to treat
The randomized, double masked, placebo controlled Phase II trial has enrolled a total of 142 treatment naive wet-AMD patients at more than 20 clinical sites in the US.
ILUVIEN is Alimera’s sustained release intravitreal injection for the treatment of diabetic macular edema. As part of the deal, STA will also be responsible for managing all regulatory
The petition was made pursuant to Section 22A of the Medicines and Related Substances Act No. 101 of 1965, which provides for pharmaceutical research with cannabis. Apart from
The platform was selected after an extensive evaluation process carried out by members of the Quality Assurance and IT teams at Pierre. Initially, the QUMAS solution will be
As part of the deal, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display platform, while Merck will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.